Englander Institute for Precision Medicine

Publications

Found 695 results
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Ceder Y, Bjartell A, Culig Z, Rubin MA, Tomlins S, Visakorpi T.  2016.  The Molecular Evolution of Castration-resistant Prostate Cancer.. Eur Urol Focus. 2(5):506-513.
Charilaou P, Mohapatra S, Doukas S, Kohli M, Radadiya D, Devani K, Broder A, Elemento O, Lukin DJ, Battat R.  2023.  Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach.. J Gastroenterol Hepatol. 38(2):241-250.
Charpentier M, Bloy N, Formenti SC, Galluzzi L, Demaria S.  2024.  Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids.. J Vis Exp. (206)
Chávez ASOliva, Wang X, Marnin L, Archer NK, Hammond HL, Carroll EEMcClure, Shaw DK, Tully BG, Buskirk AD, Ford SL et al..  2021.  Tick extracellular vesicles enable arthropod feeding and promote distinct outcomes of bacterial infection.. Nat Commun. 12(1):3696.
Che M, Chaturvedi A, Munro SA, Pitzen SP, Ling A, Zhang W, Mentzer J, Ku S-Y, Puca L, Zhu Y et al..  2021.  Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer.. Nat Commun. 12(1):6377.
Chen X, Tsvetkov AS, Shen H-M, Isidoro C, Ktistakis NT, Linkermann A, Koopman WJH, Simon H-U, Galluzzi L, Luo S et al..  2024.  International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis.. Autophagy.
Chen HJoyce, Gardner EE, Shah Y, Zhang K, Thakur A, Zhang C, Elemento O, Varmus H.  2023.  FORMATION OF MALIGNANT, METASTATIC SMALL CELL LUNG CANCERS THROUGH OVERPRODUCTION OF cMYC PROTEIN IN TP53 AND RB1 DEPLETED PULMONARY NEUROENDOCRINE CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS.. bioRxiv.
Chen HJoyce, Poran A, Unni AM, Huang SXuelian, Elemento O, Snoeck H-W, Varmus H.  2019.  Generation of pulmonary neuroendocrine cells and SCLC-like tumors from human embryonic stem cells.. J Exp Med. 216(3):674-687.
Chennamadhavuni A, Kasi PMurtaza.  2022.  Circulating Tumor DNA in Identifying Resistant Sub-Clones Post EGFR Blockade: Implications for EGFR Rechallenge.. Front Oncol. 12:847299.
Cheong J-G, Ravishankar A, Sharma S, Parkhurst CN, Grassmann SA, Wingert CK, Laurent P, Ma S, Paddock L, Miranda IC et al..  2023.  Epigenetic memory of coronavirus infection in innate immune cells and their progenitors.. Cell. 186(18):3882-3902.e24.
Chetnik K, Benedetti E, Gomari DP, Schweickart A, Batra R, Buyukozkan M, Wang Z, Arnold M, Zierer J, Suhre K et al..  2022.  maplet: an extensible R toolbox for modular and reproducible metabolomics pipelines.. Bioinformatics. 38(4):1168-1170.
Chin AF, Han J, Clement CC, Choi Y, Zhang H, Browne M, Jeon OHee, Elisseeff JH.  2023.  Senolytic treatment reduces oxidative protein stress in an aging male murine model of post-traumatic osteoarthritis.. Aging Cell. 22(11):e13979.
Cho BAngela, Iyengar NM, Zhou XKathy, Morrow M, Giri DD, Verma A, Elemento O, Pollak M, Dannenberg AJ.  2021.  Blood biomarkers reflect the effects of obesity and inflammation on the human breast transcriptome.. Carcinogenesis. 42(10):1281-1292.
Choi S, Whitman MA, Shimpi AA, Sempertegui ND, Chiou AE, Druso JE, Verma A, Lux SC, Cheng Z, Paszek M et al..  2023.  Bone-matrix mineralization dampens integrin-mediated mechanosignalling and metastatic progression in breast cancer.. Nat Biomed Eng. 7(11):1455-1472.
Choi S, Wang D, Chen X, Tang LH, Verma A, Chen Z, Kim BJung, Selesner L, Robzyk K, Zhang G et al..  2019.  Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression.. Mol Cancer. 18(1):92.
Chong SJun Fei, Marchi S, Petroni G, Kroemer G, Galluzzi L, Pervaiz S.  2020.  Noncanonical Cell Fate Regulation by Bcl-2 Proteins.. Trends Cell Biol. 30(7):537-555.
Chu C-S, Hellmuth JC, Singh R, Ying H-Y, Skrabanek L, Teater MR, Doane AS, Elemento O, Melnick AM, Roeder RG.  2020.  Unique Immune Cell Coactivators Specify Locus Control Region Function and Cell Stage.. Mol Cell. 80(5):845-861.e10.
Chu SH, Huang M, Kelly RS, Benedetti E, Siddiqui JK, Zeleznik OA, Pereira A, Herrington D, Wheelock CE, Krumsiek J et al..  2019.  Integration of Metabolomic and Other Omics Data in Population-Based Study Designs: An Epidemiological Perspective.. Metabolites. 9(6)
Chukwu W, Lee S, Crane A, Zhang S, Mittra I, Imielinski M, Beroukhim R, Dubois F, Dalin S.  2023.  Genomic sequence context differs between germline and somatic structural variants allowing for their differentiation in tumor samples without paired normals.. bioRxiv.
Ciani Y, Fedrizzi T, Prandi D, Lorenzin F, Locallo A, Gasperini P, Franceschini GMarco, Benelli M, Elemento O, Fava LL et al..  2022.  Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer.. Cell Syst. 13(2):183-193.e7.
Cibula D, Rob L, Mallmann P, Knapp P, Klat J, Chovanec J, Minar L, Melichar B, Hein A, Kieszko D et al..  2021.  Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial.. Gynecol Oncol. 162(3):652-660.
Ciccarese C, Iacovelli R, Sternberg CN, Gillessen S, Tortora G, Fizazi K.  2022.  Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysis.. Eur J Cancer. 173:276-284.
Ciccolella S, Ricketts C, Gomez MSoto, Patterson M, Silverbush D, Bonizzoni P, Hajirasouliha I, Vedova GDella.  2021.  Inferring cancer progression from Single-Cell Sequencing while allowing mutation losses.. Bioinformatics. 37(3):326-333.
Claps M, Mennitto A, Guadalupi V, Sepe P, Stellato M, Zattarin E, Gillessen SSilke, Sternberg CN, Berruti A, De Braud FGuglielmo et al..  2020.  Immune-checkpoint inhibitors and metastatic prostate cancer therapy: Learning by making mistakes.. Cancer Treat Rev. 88:102057.
Clement CC, D'Alessandro A, Thangaswamy S, Chalmers S, Furtado R, Spada S, Mondanelli G, Ianni F, Gehrke S, Gargaro M et al..  2021.  3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine.. Nat Commun. 12(1):4447.